Clinical Study
Citrate Anticoagulation for CRRT in Children: Comparison with Heparin
Table 1
Composition of the solutions.
| | PrismOcal | PrismOcal B22 | Prismocitrate |
Hemosol B0 |
Clear-flex D6 |
Phoxilium | 10/2 | 18 |
| Volume | 5000 mL | 5000 mL | 5000 | 5000 | 5000 mL | 3000 mL | 5000 mL | Na mmol/L | 140 | 140 | 136 | 140 | 140 | 140 | 140 | K mmol/L | 0 | 4 | 0 | 0 | 0 | 0 | 4 | Cl mmol/L | 106 | 120 | 106 | 86 | 109.5 | 100 | 115.9 | Ca mmol/L | 0 | 0 | 0 | 0 | 1.75 | 0 | 1.25 | Mg mmol/L | 0.5 | 0.75 | 0 | 0 | 0.5 | 0 | 0.6 | CO3H | 32 | 22 | 0 | 0 | 32 | 40 | 30 | Lactate | 3 | 3 | 0 | 0 | 3 | 0 | 0 | Glucose mg/dL | 0 | 109.8 | 0 | 0 | 0 | 0 | 0 | Phosphate mmol/L | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | Citrate/citric acid mmol/L | | | 10/2 | 18/0 | | | | Administration route | Dialysis | Dialysis | IV PBP* | IV PBP* | Postfilter substitution | Pre- or postfilter substitution | Postfilter substitution |
|
|
PBP: placed in a pump before blood pump.
|